ICICI Prudential Mutual Fund purchased 15,295 shares of Ethos on May 7, 2025. Through its different schemes, it previously acquired 5,54,721 shares of the company on December 9, 2022. Currently ...

ICICI Prudential Mutual Fund purchased 15,295 shares of Ethos on May 7, 2025. Through its different schemes, it previously acquired 5,54,721 shares of the company on December 9, 2022.

The concept traces back to Ancient Greece, where Aristotle’s treatise “Rhetoric” established the three pillars of persuasion: ethos, logos, and pathos. While ethos establishes credibility ...

Since the earliest days of human civilization, communication has been the defining force behind cultural development and societal progress. From the rhythmic beats of ancient drums to the ...

COLUMBUS, Ohio & BOSTON & TORONTO — BroadStreet Partners (“BroadStreet” or the “Company”), a leading North American insurance brokerage company, announced today that an investor group led by Ethos ...

ZURICH, March 27 (Reuters) - Proxy advisory firm Ethos on Thursday urged UBS (UBSG.S), opens new tab shareholders to reject the bank's remuneration, share buyback program and sustainability report ...

(Dave Grim/U.S. Space Force) U.S. policies around weapons in space, its over-classification of space capabilities and a lacking “warfighting ethos” are undermining public perception of the ...

Aristotelian rhetorical strategies—ethos, pathos, and logos—remain critical for persuasive communication, particularly in political oratory. Implementing these strategies in radio broadcasts presents ...

as the extension of benefits of reservation to people with such ulterior motives will only defeat the social ethos of the policy of reservation," he noted. The top court highlighted that ...

Jaguar Land Rover has changed its branding, and the reveal is causing people to take a second look. In a post on X, formerly Twitter on Tuesday, the luxury vehicle company shared a video with a ...

CHICAGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Pathos AI, a clinical-stage biotechnology company focused on re-engineering drug development through artificial intelligence, today announced the closing ...